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Abstract. Senescent cells do not proliferate in response 
to exogenous growth factors, yet the number and affin- 
ity of growth factor receptors on the cell surface appear 
to be similar to presenescent cell populations. To deter- 
mine whether a defect in receptor signaling exists, we 
analyzed human umbilical vein endothelial cells (HU- 
VEC) since HUVEC growth is absolutely dependent 
upon the presence of FGF. We report that in both pre- 
senescent and senescent HUVEC populations, FGF-1 
induces the expression of cell cycle-specific genes, sug- 
gesting that functional FGF receptor (FGFR) may exist 
on the surface of these cells. However, the tyrosine 
phosphorylation of FGFR-1 substrates, Src and cortac- 
tin, is impaired in senescent HUVEC, and only the pre- 
senescent cell populations exhibit a FGF-l-dependent 
Src tyrosine kinase activity. Moreover, we demonstrate 
that senescent HUVEC are unable to migrate in re- 
sponse to FGF-1, and these data correlate with an al- 
tered organization of focal adhesion sites. These data 
suggest that the induction of gene expression is insuffi- 
cient to promote a proliferative or migratory pheno- 
type in senescent HUVEC and that the attenuation of 
the FGFR-1 signal transduction pathway may be in- 
volved in the inability of senescent HUVEC to prolifer- 
ate and/or migrate. 
ARLY studies  of cellular  senescence  have  demon- 
strated that the in vitro lifespan of human diploid 
fibroblasts is finite and is a function of the cumula- 
tive population doublings (17, 35, 47). These phenomena 
have been associated with different cell types, and the hu- 
man endothelial cell presents an interesting alternative for 
the study of cellular senescence in vitro. Unlike the fibro- 
blast,  the  human  umbilical  vein  endothelial  cell  (HU- 
VEC) 1 is absolutely dependent upon the presence of FGF 
for in vitro proliferation and serial propagation (26).  It is 
well established that senescent HUVEC are refractory to 
the mitogenic potential of FGF (46).  Further, it has been 
demonstrated that although FGF is a potent mitogen for 
HUVEC, its function is antagonized in the presence of the 
cytokine interleukin (IL)-I (6, 30),  and IL-la may act in- 
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tracellularly to inhibit proliferation (14). Indeed, this labo- 
ratory has shown that an exaggerated level of intracellular 
IL-la exists in senescent HUVEC (15), which may func- 
tion to repress FGF-l-induced HUVEC growth in senes- 
cent populations (27). 
The fibroblast growth factor receptor (FGFR) signaling 
pathway has been defined (12) and includes the tyrosine 
kinase activation of the FGFR and subsequent phosphoty- 
rosine modification of a variety of intracellular substrates, 
including Src (51, 53). Src, a member of a family of cytoso- 
lic tyrosine kinases,  is  thought to  be  involved in  signal 
transduction  events underlying growth control  (5).  The 
protein kinase activity of Src is negatively regulated when 
tyrosine 527 is phosphorylated by another tyrosine kinase, 
Csk (28, 31, 33, 39). It has been suggested that Csk medi- 
ates the activity of Src through its own SH2 and SH3 do- 
mains, and these are required to target Csk to sites where 
Src is active (18).  In addition, the phosphorylation of Src 
Y527 as well as the SH2 and SH3 domains in the amino 
terminus of Src have been identified as important regula- 
tory regions responsible for the redistribution of Src from 
cellular membranes to focal adhesion sites (21,  22).  Be- 
cause several Src substrates are localized to focal adhesion 
sites  (41),  the redistribution of activated Src  suggests it 
may play a role in the regulation of cell adhesion. Indeed, 
it has recently been shown that Src can function during the 
early stages of fibronectin-mediated cellular adhesion of 
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been shown to be associated with stationary cells, they also 
will form at the leading edge of motile cells (3), suggesting 
that Src may also function in the regulation of cell migra- 
tion, and an increased tyrosine phosphorylation in the fo- 
cal  adhesions  of migrating  HUVEC  has  been observed 
(38).  In  addition,  a  Src-dependent increase in  tyrosine 
phosphorylation of several cytoskeletal proteins, includ- 
ing cortactin (45), has also been demonstrated. Cortactin is 
a  filamentous (F)-actin binding protein that contains an 
SH3 domain and can be phosphorylated on both serine/ 
threonine and tyrosine residues (49, 50).  Our laboratory 
identified murine cortactin as a substrate for Src and dem- 
onstrated an association between cortactin and Src during 
the entire G1 phase of cell cycle after activation of Balb/c 
3T3 cells by FGF-1 (52, 53). Thus, the FGF-1 signal trans- 
duction pathway appears to include  the  association and 
phosphorylation of FGFR-1 and Src and the association of 
Src with cortactin, and these events may affect cellular pro- 
liferation, migration, and cytoskeletal properties. 
Although senescent cells do not proliferate in response 
to exogenous growth factors, the number and affinity of 
growth factor receptors appear to be similar in presenes- 
cent and senescent populations (7, 10, 36, 43). However, in 
senescent WI-38 fibroblasts, Fos transcription in response 
to serum (42) and the protein tyrosine kinase activity of 
the  epidermal growth factor receptor (EGFR)  (4)  have 
been shown to be compromised, suggesting that a defect in 
receptor signaling may exist. To determine the nature of 
such  a  defect,  we  analyzed  HUVEC  populations  since 
HUVEC growth is  absolutely dependent upon the pres- 
ence of exogenous FGF (26). We observed an induction of 
cell  cycle-specific genes  in  response  to  FGF-1  in  both 
early and late passage  cells, suggesting that a  functional 
FGFR may be present on the surface of these cells. How- 
ever, analysis of the ability of the FGFR to induce the ty- 
rosine phosphorylation of its substrates revealed that al- 
though  presenescent HUVEC  populations were  able  to 
induce the tyrosine phosphorylation of Src and cortactin in 
response to FGF-1, senescent HUVEC were unable to do 
so. Further, the presenescent HUVEC exhibited a FGF-1- 
dependent Src tyrosine kinase activity, but senescent cells 
revealed a baseline level of kinase activity that was inde- 
pendent of the presence of FGF-1. These data suggest that 
the inability of senescent HUVEC to respond to FGF-1 
may involve a defect downstream and/or independent of 
receptor binding and activation of gene expression. Fur- 
ther, we were able to demonstrate that senescent HUVEC 
were unable to migrate in response to FGF-1, which corre- 
lated with  prominent focal adhesion sites. Thus, despite 
the ability of the FGFR to signal gene expression in senes- 
cent HUVEC, the FGF-1--dependent proliferative and mi- 
gratory responses appear to be compromised, and these 
responses may involve the inability of the cells to use the 
FGFR pathway to signal the tyrosine phosphorylation of 
Src and the inability of Src to phosphorylate cortactin. 
Materials and Methods 
Cell Culture 
HUVECs, strain H3605,  used in these experiments were a generous gift 
from M. Gimbrone (Harvard Medical School, Boston, MA). HUVECs 
were serially passaged at 1:5 split ratios in medium 199 (RHJ Biosciences, 
Lenexa, KS) supplemented with  10%  (vol/vol) FBS, heparin (Upjohn, 
Kalamazoo,  MI;  5  U/ml),  lx  antibiotic-antimycotic  (GIBCO,  BRL, 
Gaithersburg, MD), and crude bovine FGF-1 (150  ~xg/ml) in cell culture 
dishes coated with fibronectin (5 ~g/cm2). Human fibronectin and crude 
preparations of bovine FGF-I were prepared as previously described (26). 
At each passage, the cells were trypsinized when confluent, counted in a 
hemacytometer, and seeded at known cell densities. The population dou- 
bling level was calculated as described (26).  Cells with <25 cumulative 
population doublings (CPDs) were considered presenescent and cells with 
more than 60 CPDs were considered senescent. The senescent cells used 
in these experiments completed 90-95% of their lifespan and were main- 
tained in culture for at least 7 d without an increase in cell number. Fur- 
ther, in situ labeling experiments were performed according to the meth- 
ods of Stein et al. (44).  To determine the labeling index, [3H]thymidine- 
positive nuclei were counted in 10 or 20 fields in presenescent or senescent 
cells, respectively. The presenescent HUVEC (CPD 24) had 85% of the 
nuclei labeled, whereas in the near-senescent populations (CPD  65), only 
8% of the nuclei were labeled. 
RNA Extraction, Northern Blot Analysis, and Reverse 
Transcriptase-Polymerase  Chain Reaction 
Total RNA was extracted from HUVEC monolayers by the guanidinium 
isothiocyanate procedure as described (14). RNA (10 I~g) was separated 
on 0.8% agarose gels and capillary-blotted onto Zeta-Probe nylon mem- 
branes (BioRad Labs, Hercules, CA). 3Zp-labeled  eDNA probes were 
hybridized to the RNA at 65°C for 18 h. The membranes were washed 
at high stringency and exposed on Kodak X-AR film (Rochester, NY) at 
-80°C. The Fos and glyceraldehyde-3-phosphate  dehydrogenase (GAPDH) 
cDNAs  were  purchased  from  the  American  Type  Culture  Collection 
(Rockville, MD). The histone 3.2 (H3) eDNA was a generous gift from J. 
Campisi (Berkley, CA), and the human ornithine decarhoxylase (ODC) 
eDNA was provided by J.K. deRiel (Temple University, Philadelphia, PA). 
Reverse transcription polymerase chain reaction (RT-PCR) was per- 
formed using 1 I~g total RNA as described (14).  The eDNA was diluted 
with 1-t20 to 500 txl and PCR was performed with 5 I~1 of each sample am- 
plified by denaturation at 94°C for 1 min, annealed at 54°C for 2 rain, and 
elongated at 72°C for 3 min using 35 cycles for the FGFR family and 32 cy- 
cles for GAPDH. Specific primer sequences for each gene were as follows: 
FGFR-I: sense: 5'-AAGGACAAACCCAACCGTGTGACC-3', antisense: 
5'-CCCAAAGTCTGCTATCYrCATCAC~3'; FGFR-2: sense: 5'-CTGTG- 
CCGAATGAAGAACACGACC-3', antisense: 5'-CCCAAAGTCTGC- 
TATCTFCATCAC-3'; FGFR-3: sense: 5'-TGAGGACACAGGTGTGG- 
ACACAGG-3', antisense: 5'-TCTGCCGGATGCTGCCAA  ACTTGT-3'; 
FGFR-4: sense: 5'-CTCGCCGGCCTCGTGAGTCTAGAT-3',  antisense: 
5'-CCCAAAGTCTGCTATCTTCATCAC-3'; GAPDH: sense: 5'-CCA- 
CCCATGGCAAATI'CCATGGCA-3', antisense: 5'-TCT AGACGGCA- 
GGTCAGGTCCACC-3'. 
lmmunoprecipitation and Western Blot or In Vitro 
Kinase Analysis 
Presenescent and senescent populations of HUVEC were incubated for 
7.5 h in media lacking FGF-1 and heparin and containing 3% FBS and 20 
ng/ml PMA. The cells were washed twice with PBS and incubated for a to- 
tal of 24 or 48 h in media containing 1.5% FBS. FGF-1 (10 ng/ml) and he- 
parin (10 p~g/ml) were added for the indicated times and the cells were 
scraped into t  ml PBS and collected by centrifugation (5 s). The cell pel- 
lets were lysed in 1 ml RIPA (10 mM Tris-HCl, pH7.5, 1 mM EDTA, 150 
mM NaC1, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X-100) con- 
taining 1 mM PMSF, 2 ixg/ml aprotinin, I0 IJ,  g/ml leupeptin, and 1 mM 
Na3VO4 and incubated on ice for 5 min. The cell lysates were centrifuged 
at 4°C for 10 min and the supernatants were transferred to fresh tubes. 
Specific antibodies were incubated with cell lysates and rotated at 4°C for 
1 h followed by the addition of 20 Ixl Protein A-Sepharose (Pharmacia 
LKB Biotechnology Inc., Piscataway, NJ) and rotation at 4°C for 1 h. The 
immunoprecipitates were washed three times with RIPA b~ffer, dissolved 
in SDS-sample buffer (125 mM Tris-HCl, pH 6.8, 2% SDS710% glycerol, 
0.001% bromophenol blue), and resolved by SDS-PAGE using 7.5% (wt/ 
vol) acrylamide gels. The proteins were transferred to 0.2 ~m nitrocellu- 
lose membranes, and Western blot analysis was performed with specific 
antibodies in  Tris-buffered saline  (20  mM Tris-HCl, pH  7.6,  137  mM 
NaCI, 0.1%  Tween-20) containing either 5%  milk  (Src-2 blots) or 5% 
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sham Corp., Arlington Heights, IL) according to the manufacturer's in- 
structions. 
To analyze the tyrosine kinase activity of Src, in vitro kinase assays 
were performed. The cells were lysed and immunoprecipitated with Src- 
specific antibodies as described above, washed with kinase buffer (30 mM 
Tris-HC1,  pH 7.4,  10 mM MnCI2),  and then incubated in 50  ixl kinase 
buffer containing 2 p.g acid-denatured enolase (Sigma lmmunochemicals, 
St. Louis, MO) and 10 p.Ci ~/[32p]ATP for 10 rain at room temperature. 
The phosphorylated proteins were visualized by autoradiography of dried 
10% (wt/vol) polyacrylamide gels following SDS-PAGE. 
Antibodies 
The antibodies for immunoblot analysis included: (a) polyclonal rabbit 
anti-human Src (N-16; Santa Cruz Biotechnology, Santa Cruz, CA), an 
antibody raised against a peptide corresponding to the unique residues 
3-18 within the amino terminus of the human Src gene and used for Src 
immunoprecipitation; (b) Src-2 (Santa Cruz Biotechnology), a polyclonal 
antibody raised against a peptide corresponding to the carboxyl terminus 
of Src and cross-reactive with Yes and Fyn and used for Src Western blot 
analysis;  (c)  monoclonal  antiphosphotyrosine  (Upstate  Biotechnology 
Inc., Lake Placid, NY) used for Western blot analysis; (d) polyclonal rab- 
bit anti-mouse cortactin antisera 2719, generated from a peptide antigen 
(residues 343-362 of murine eortactin) injected into rabbits and used for 
immunoprecipitation of cortaetin protein (52); and (e) anticortactin antis- 
era 001, generated from recombinant murine cortactin expressed as a glu- 
tathione S-transferase fusion protein and used for Western blot analysis of 
cortactin (53). 
HUVEC Migration Assays 
Monolayers of early and late passage HUVEC were wounded as previ- 
ously described (40).  Briefly, confluent monolayers were scraped with a 
razor blade and cellular debris was removed by washing with PBS. The 
monolayers were incubated for 16-20 h at 37°C in medium 199 containing 
10% FBS alone (control) or supplemented with FGF-1 (10 ng/ml), hep- 
arin (10  ~g/ml), rIL-lc~  (10 ng/ml), IL-1 receptor antagonist IRAP; (100 
ng/ml), or PMA (20 ng/ml) as indicated in the text. The cells were then 
fixed in 25%  acetic acid/75%  methanol and stained with hematoxylin 
(Sigma  Immunochemicals).  The  number  of  ceils  migrating  from  the 
wound origin was counted with a light microscope at 100 magnification us- 
ing a grid. The values represent the mean of five fields, and three separate 
experiments have been performed with each condition tested in duplicate. 
Immunofluorescence 
Presenescent and  senescent HUVEC  were  plated  on  glass coverslips 
coated with fibronectin, incubated for 24 h in medium 199 containing 10% 
FBS, lX  antibiotic-antimycotic, 10 ng/ml FGF-1  and 10 ixg/ml heparin, 
and then fixed in ice-cold acetone. The coverslips were dried, incubated in 
immunofluorescence-blocking buffer (PBS containing 5% bovine serum 
albumin, 0.1% Triton-X 100, 0.1% Tween-20, 0.1% NAN3) for 1 h, washed 
three times with PBS, and incubated 1 h with antibody diluted 1:50 in PBS 
(monoclonal  antivinculin  antibody  [Sigma  Immunochemicals];  mono- 
clonal antiphosphotyrosine antibody [Upstate Biotechnology Inc.]; and 
rabbit antiserum for the fibronectin receptor [¢t5~1], a  gift from S. Ar- 
graves, Holland Laboratory). The coverslips were washed three times in 
PBS, incubated 30 min in fluorescein-conjugated goat anti-mouse or anti- 
rabbit antibodies, washed three times in PBS, and embedded in 50% glyc- 
erol with 0.1%  phenylenediamine. The cells were photographed with a 
fluorescence microscope at 600 magnification (Olympus Corp., Lake Suc- 
cess, NY). 
Results 
Expression of Cell Cycle-Specific Genes in 
Presenescent and Senescent HUVEC 
It has been suggested that a  defect in receptor signaling 
may exist in senescent cell populations (4). Because HU- 
VEC are absolutely dependent upon the presence of FGF-1 
for  proliferation,  we  have  studied  the  FGF-l-signaling 
pathway in senescent HUVEC to better understand the 
processes that may be involved in regulating cellular se- 
nescence in vitro. There are currently four FGFR genes 
that  have been identified (12).  RT-PCR analysis  of the 
steady state level of the FGFR gene family demonstrated 
that the primary gene, which is expressed at similar levels 
in both presenescent and senescent HUVEC populations, 
is the FGFR-1 transcript (Fig. 1 C). The total number of 
FGFR-1 on the surface of HUVEC is extremely low (13) 
and is not detectable using standard methods of FGFR im- 
munoprecipitation followed by either immunoblot analy- 
sis or by an in vitro kinase assay (data not shown). Thus, 
we have chosen to study the functional aspects of FGFR-1 
signaling  through  the  expression  of  immediate-early 
(IME) and mid-to-late (MTL) cell cycle-dependent genes. 
This approach was taken because cell cycle-specific gene 
expression has been used as a marker for the progression 
of cells through the Gt and S phases in response to growth 
factors  (32,  42).  Early  and  late  passage  HUVEC  were 
made quiescent in media lacking FGF-1 and heparin, and 
then treated with FGF-1 for the indicated times (Fig. 1). 
Northern blot analysis revealed that both HUVEC popu- 
lations treated with FGF-1 and cycloheximide (chx) dem- 
onstrated a superinduction of the IME gene, Fos, as com- 
pared to the induction with chx alone (Fig. 1 A). Because 
Northern blots are not as sensitive as PCR, we used chx to 
visualize the very low level of Fos mRNA in HUVEC (Fig. 
1 A); however, these results are consistent with RT-PCR 
in which an induction of Fos mRNA was also observed in 
presenescent and senescent populations treated with FGF-1 
alone  (data  not  shown).  In  addition,  we  analyzed  the 
mRNA expression of the MTL genes, ODC and H3, and 
found that ODC was induced in response to FGF-1 in two 
different strains of early and late passage HUVEC (Fig. 
1 B). Further, although the steady state level of H3 mRNA 
appears to be decreased in the senescent HUVEC popula- 
tions, a FGF-1 induction was observed in the presenescent 
and senescent cells from both strains (Fig. 1 B). Thus, it 
appears that FGF-1 is capable of signaling an induction of 
gene expression through the FGFR-1  on the  surface  of 
presenescent, as well as senescent, HUVEC populations. 
The FGF-1--dependent Tyrosine Phosphorylation 
of FGFR-1 Substrates and FGF-l-dependent 
Tyrosine Kinase Activity of Src Is Impaired in 
Senescent HUVEC 
The  results  described  above  imply  that  the  functional 
properties of the FGFR-1 in senescent HUVEC are not 
impaired. However, FGF-1 mutants  and FGF-1  chimera 
proteins have shown that FGFR-binding activity and pro- 
tooncogene expression can occur without mitogenic activ- 
ity (2, 20) and FGF-l-induced DNA synthesis may occur 
without increases in the level of tyrosine phosphorylation 
(48). Therefore, because the dissociation of cellular events 
has been described, we questioned whether FGFR-1 sig- 
naling was functional for the tyrosine phosphorylation of 
receptor substrates  in  presenescent  and  senescent  HU- 
VEC. Our laboratory previously identified two predomi- 
nant tyrosine phosphorylated proteins in FGF-l-treated 
Balb/c 3T3 cells during the MTL G1 phase of the cell cycle 
with molecular weights of 80 and 60 kD, corresponding to 
Garfinkel et al. FGF Receptor Signaling in Human Endothelial Cells  785 Figure 1.  Expression of cell cycle-specific genes in presenescent and senescent populations of HU- 
VEC.  (A) Presenescent (young; Y) and senescent (S) HUVEC monolayers of strain H3605  were 
starved for 48 h in media lacking FGF-1, and then stimulated for 1 or 2 h with FGF-1 (10 ng/ml), he- 
parin (10 Ixg/ml) and cycloheximide (chx; 10 txg/ml), or chx only, as indicated. Total RNA was puri- 
fied and 10 I~g was separated on agarose gels for Northern blot analysis using a 32p-labeled cDNA 
probe specific for Fos. The filter was stripped and rehybridized to a  radiolabeled GAPDH cDNA 
probe to confirm that each sample contained similar RNA levels. (B) Presenescent (young; Y) and 
senescent (S) cells from HUVEC strains H3605 and H928 were starved for 48 h and then stimulated 
with FGF-1 (10 ng/ml) and heparin (10 txg/ml) for 1 or 24 h. Total RNA was purified and 10 Ixg was separated on agarose gels for Northern 
blot analysis using ornithine decarboxylase (ODC) or histone 3.2 (H3) 32p-labeled cDNA probes. The gel was stained with ethidium 
bromide to determine the amount of RNA per lane. (C) Total RNA was purified from presenescent (young; 11) and senescent (S) HU- 
VEC monolayers (strain H3605) and used for RT-PCR with sense and antisense primers for the FGFR gene family and GAPDH (see 
Materials and Methods). The products of amplification were separated on a 1% agarose gel and stained with ethidium bromide. 
murine cortactin and  Src, respectively (51-53).  Immuno- 
precipitation of presenescent HUVEC  populations with a 
Src-specific  antibody  followed  by  antiphosphotyrosine 
immunoblot  analysis showed  a  FGF-l-dependent  induc- 
tion  of Src tyrosine phosphorylation (Fig. 2  A). Interest- 
ingly, in several experiments with early passage HUVEC, 
Src poorly induced the tyrosine phosphorylation of cortac- 
tin in response to FGF-1 (Fig. 2 B). In contrast, senescent 
HUVEC  populations were impaired in their ability to in- 
duce  the  tyrosine phosphorylation of Src in  response  to 
FGF-1 and displayed little if any tyrosine phosphorylated 
cortactin, despite similar protein levels in both presenes- 
cent  and  senescent  populations  (Fig.  2).  To  quantitate 
these results, the autoradiographs were evaluated by den- 
sitometric scanning, dividing the intensity of the phosphor- 
ylated Src  or  cortactin  band  by the  appropriate  protein 
Figure  2.  The  FGF-I-in- 
duced tyrosine phosphoryla- 
tion  of Src  and  cortactin  is 
impaired  in  senescent  HU- 
VEC.  Presenescent  (young; 
Y)  and  senescent  (S)  HU- 
VEC from strain H3605 were 
starved for a total of 24 h and 
then treated with FGF-1 and 
heparin for 18 or 24 h as de- 
scribed  in  Materials  and 
Methods. The cells were col- 
lected,  lysed,  and  immuno- 
precipitated with  antibodies 
specific for (A) Src, N-16,  or 
(B)  cortactin, 4~2719, as de- 
scribed  in  Materials  and 
Methods. The immunoprecipitates were resolved by SDS-PAGE using 7.5% polyacrylamide gels, and Western blot analysis was per- 
formed using antiphosphotyrosine antibodies (anti-P-Tyr), Src antibodies (anti-Src), or cortactin antibodies (anticortactin). 
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Figure 3.  The tyrosine kinase activity of Src is impaired in senes- 
cent HUVEC. (A) Presenescent (young) and senescent  HUVEC 
from strain  H3605 were  starved for  a  total of 48  h  and  then 
treated with FGF-1 and heparin for 6 h as described  in Materials 
and  Methods.  The  cells were  collected, lysed, and  immunopre- 
cipitated with an antibody specific for Src, and an in vitro kinase 
assay  was performed using  the  substrate  enolase.  After  SDS- 
PAGE, phosphorylated Src and enolase were visualized by auto- 
radiography (upper), and the level of Src protein was visualized 
by Western blot analysis  with  anti-Src  antibodies  (lower).  (B) 
The specific Src kinase activity was calculated by dividing the in- 
tensity of the enolase band (Fig. 3 A, upper) by the intensity  of 
the Src protein band (Fig. 3 A, lower, as determined by densito- 
metric scanning (Visage version 4.6P; Biolmage, Ann Arbor, MI). 
band. Src tyrosine phosphorylation in early passage HU- 
VECs was induced sixfold by FGF-1 as compared to a 1.4- 
fold induction  in senescent cells, whereas a  threefold in- 
duction of the tyrosine phosphorylation of cortactin was 
observed in early passage HUVEC treated with FGF-1 as 
compared to no induction in senescent cells. A  second ex- 
periment showed similar results (data not shown). These 
data  suggest  that  while  senescent  HUVEC  possess  the 
ability to use the FGFR-1 pathway to regulate the FGF-1- 
induced mRNA levels of various cell cycle-specific genes, 
they  are  impaired  in  their  ability  to  signal  the  tyrosine 
phosphorylation of the FGFR-1 substrates Src and cortactin. 
Because it is likely that the FGF-l-signaling pathway in- 
volves the association of the FGFR-1 with Src and the as- 
sociation of Src with cortactin (53) and the FGF-1--depen- 
dent  tyrosine  phosphorylation  of  Src  was  impaired  in 
senescent HUVEC, we analyzed the activity of Src in pre- 
senescent and senescent HUVEC populations using an in 
vitro kinase  assay. Immunoprecipitation of Src followed 
by  an  in  vitro  kinase  assay  using  the  substrate  enolase 
demonstrated  that  a  FGF-1--dependent  induction  of Src 
kinase activity was observed in the early passage HUVEC 
(Fig.  3).  In  contrast,  Src-specific  immunoprecipitation 
from senescent HUVEC populations revealed that a  low 
level of Src tyrosine kinase activity was independent of the 
presence of FGF-1. The specific Src kinase activity calcu- 
lated by dividing the intensity of the enolase band by the 
intensity of the Src protein band revealed a baseline level 
of  Src  tyrosine  kinase  activity  in  the  presenescent  un- 
treated,  as  well  as  the  senescent,  HUVEC  populations 
(Fig. 3 B). We evaluated the phosphorylation of enolase as 
a measure of specific Src tyrosine kinase activity because 
the  autophosphorylation  of Src has  been inconsistent  in 
many experiments performed and was often too low to ac- 
curately quantitate.  Despite the levels of phosphorylated 
Src observed in Fig. 3 A, which by densitometric scanning 
shows a  twofold induction by FGF-1 in both cell popula- 
tions, we hesitate to state that this is a  specific FGF-1 ef- 
fect because of the inconsistencies that we have observed. 
Thus, in senescent HUVEC, Src is unable to phosphory- 
late its substrate cortactin but shows a baseline level of en- 
zymatic activity to phosphorylate enolase, which is inde- 
pendent of the presence of FGF-1. 
Senescent HUVEC Do Not Migrate in Response 
to FGF-1, Which Correlates with Prominent Focal 
Adhesion Sites 
It has been determined that inhibition of migration of hu- 
man fibroblasts and bovine aortic endothelial cells occurs 
during in vitro senescence (1, 24, 29, 34). Because we have 
established that senescent HUVEC are defective in their 
ability  to  induce  the  phosphotyrosine  of  FGFR-1  sub- 
strates  and  an  increase  in  tyrosine  phosphorylation  has 
been observed in migrating HUVEC (38), we questioned 
whether senescent HUVEC were capable of migration in 
response to FGF-1. In addition, because our previous re- 
suits demonstrated that senescent HUVEC exhibited ele- 
vated levels of IL-lct (15), we also analyzed the ability of 
early passage HUVEC to respond to IL-let as a chemoat- 
tractant.  While FGF-1 was  able to  elicit  a  migratory re- 
sponse in presenescent HUVEC populations, neither IL-let 
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do not migrate in response to 
FGF-1 and exhibit an abun- 
dance of focal adhesion sites. 
(A) Presenescent (Young) 
and senescent HUVEC mono- 
layers from strain H3605 
were used for migration as- 
says as described in Material 
and Methods. The number of 
cells migrating from the 
wound origin were counted 
with a light microscope at 100 
magnification using a grid, 
and the values represent the 
mean of five fields with each 
condition tested in duplicate 
and three separate experi- 
ments performed. (B) Prese- 
nescent (Young) and senes- 
cent HUVEC were processed 
for immunofluorescence as 
described in Materials and 
Methods. The cells were pho- 
tographed with a fluores- 
cence microscope at 600 mag- 
nification (Olympus Corp,). 
Presenescent (Young; A, C, 
E) and senescent (B, D, F) 
HUVEC were stained with 
antibodies for the human fi- 
bronectin receptor (a5131; A 
and B), phosphotyrosine (C 
and D), and vinculin (E and F). 
nor PMA alone had this effect (Fig. 4 A). In addition, the 
effect of FGF-1 on presenescent populations was inhibited 
in the presence of IL-let, and these effects were specifi- 
cally reversed by IRAP (9), an antagonist of IL-let action, 
whereas PMA inhibited the FGF-l-induced migration re- 
gardless of the presence of IRAP. Moreover, FGF-1 was 
unable to induce the migration of senescent HUVEC. 
In general, a decrease in cell motility correlates with 
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cent HUVEC to migrate in response to FGF-1 prompted 
us to investigate the distribution of focal adhesion sites 
(FAS)  in  presenescent  and  senescent HUVEC  popula- 
tions. Because HUVEC in culture are strongly dependent 
on fibronectin for their adherence (26) and the fibronectin 
receptor (a5131) has been implicated in mediating cell mi- 
gration (19),  we used immunofluorescence techniques to 
analyze its distribution. As compared to presenescent HU- 
VEC populations, senescent HUVEC demonstrated an al- 
tered  distribution  of fibronectin  receptor-positive  FAS 
(Fig. 4 B). The prominent FAS in senescent HUVEC were 
also demonstrated using antibodies against either vinculin, 
a protein associated with FAS, or phosphotyrosine. Thus, 
an altered organization of the expression of FAS in senes- 
cent HUVEC is consistent with the inability of these cells 
to elicit a migratory response. 
Discussion 
The HUVEC is absolutely dependent upon the presence 
of extracellular FGF for in vitro proliferation and serial 
propagation (26); however, senescent HUVEC are refrac- 
tory to the mitogenic potential of FGF (46).  Because the 
nonproliferative senescent phenotype may result from de- 
fective signaling of the FGFR and aspects of the FGFR- 
signaling pathway have been defined in established mu- 
rine cell lines (12), we analyzed normal diploid HUVEC 
populations for their ability to elicit a response to FGF-1. 
Although four FGFR family members exist, FGFR-1  is 
the primary transcript expressed in HUVEC. Because the 
level  of the  FGFR-1  on  the  surface  of HUVEC  is  ex- 
tremely low and not detectable by available methods, we 
examined the ability of FGF-1 to induce the expression of 
cell cycle-specific genes (32, 42) and the tyrosine phosphor- 
ylation of well-characterized FGFR-1 substrates (51-53). 
The expression of the IME and MTL genes, Fos, ODC, 
and H3, was induced in both early and late passage cells 
treated with FGF-1. Our results are consistent with one re- 
port demonstrating the serum inducibility of cell cycle-spe- 
cific genes  in  senescent human diploid fibroblasts  (37). 
However,  they contradict  other  reports  that  reveal  the 
lack of serum inducibility in senescent fibroblasts (32, 42), 
suggesting that human endothelial cells and fibroblasts ex- 
hibit different cellular responses to growth factors and cy- 
tokines. H3 expression is usually tightly coupled to DNA 
synthesis,  but  it  has  been  suggested  that  for  cells  to 
traverse the G1 phase of the cell cycle, a series of events is 
required and multiple pathways may act simultaneously 
(37).  Therefore, it may be possible to induce the expres- 
sion of G1 or S phase-specific genes in senescent cells, but 
additional signals are required for DNA synthesis and cell 
proliferation.  Indeed, we  have  previously demonstrated 
that maximal DNA synthesis of Balb/c 3T3 cells required 
the presence of FGF-1  throughout the entire G~ period 
and withdrawal of FGF-1, or the addition of a tyrosine ki- 
nase inhibitor in late G1, resulted ina significant reduction 
of DNA synthesis (51). In that regard, we have studied the 
tyrosine phosphorylation of FGFR-1 substrates in prese- 
nescent and senescent HUVEC. Our data suggest that un- 
like presenescent populations, senescent ceils are impaired 
in their ability to induce the FGF-1--dependent tyrosine 
phosphorylation of Src or cortactin and the tyrosine kinase 
activity of Src is not induced by FGF-1. Furthermore, we 
have shown that FGF-1 does not stimulate the migration 
of senescent HUVEC,  which correlates with prominent 
FAS as determined by the distribution of the fibronectin 
receptor, vinculin and phosphotyrosine. Thus, these data 
imply that the induction of either IME or MTL genes by 
FGF-1 is not sufficient to promote a proliferative or mi- 
gratory phenotype in senescent HUVEC populations. Fur- 
thermore, the lack of a FGF-l-dependent tyrosine phos- 
phorylation of Src and cortactin implies that this part of 
the FGFR signal transduction pathway is impaired in se- 
nescent cells and may be involved in their inability to pro- 
liferate and/or migrate. At present, we do not know the 
mechanisms involved; however, it is possible that different 
FGFR-1 signal transduction pathways exist, one pathway 
resulting in the induction of gene expression through the 
FGFR-1  and  another  involving  intracellular  substrates 
coupled to the tyrosine kinase activity of the receptor. In- 
deed, an analysis of fusion proteins of FGF-1 and diphthe- 
ria toxin has suggested that signaling occurs by two path- 
ways, partly through cell surface receptors and partly by 
transport of the growth factor into the cell cytosol and/or 
nucleus (48). Furthermore, a dissociation of FGF-l-stimu- 
lated mitogenesis from its tyrosine kinase activation has 
also been demonstrated (25).  Our attempts to define fur- 
ther the molecular mechanisms involved in the defect in 
senescent HUVEC have been hampered by the inability 
to obtain stably transfected HUVEC populations. 
Presenescent  HUVEC  populations  exhibited  a  high 
baseline  level of phosphorylated cortactin and revealed 
that Src was only minimally capable of inducing the phos- 
phorylation of cortactin in response to FGF-1 (Fig. 2 B). 
We have considered several possibilities to explain these 
data. First, the difficulty in obtaining quiescent early pas- 
sage HUVEC (16)  may give rise to background levels of 
ODC  and  H3  expression  in  untreated  cell  populations 
(Fig. 1 B) and baseline levels of Src kinase activity (Fig. 3 B). 
Thus, the level of cortactin phosphorylation in these cell 
populations may reflect a residual FGF-1 effect since it is 
difficult to completely remove endogenous FGF-1  from 
this FGF-1--dependent cell. Second, RT-PCR analysis has 
demonstrated that the transcripts for the Src family mem- 
bers  Fyn and Yes  are  expressed  in  HUVEC  (data not 
shown). Thus, it may be possible that cortactin is a  sub- 
strate for another Src family member that maintains cort- 
actin in a phosphorylated state in quiescent, presenescent 
HUVEC. Third, it is known that cortactin has multiple po- 
tential tyrosine phosphorylation sites (50),  similar to the 
phosphorylation of Src at different sites that is associated 
with its active or inactive form (5). The cortactin sites may 
be differentially phosphorylated to impart different activi- 
ties, and thus it is possible that the overall level of phos- 
phorylation changes little in presenescent HUVEC popu- 
lations treated with FGF-1, but the site of phosphorylation 
is altered. The observation that only 10-30%  of the total 
cortactin becomes  tyrosine phosphorylated in  Src-trans- 
formed avian and rodent cells (50)  is consistent with this 
premise. Fourth, cortactin has been shown to bind F-actin, 
and this binding appears to be independent of the phos- 
photyrosine state of the protein  (49).  Thus, the FGF-1- 
activated Src in presenescent HUVEC may alter cortactin in 
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of the protein. We consider this final possibility less likely 
since other studies have shown that increases  in tyrosine 
phosphorylation  correlate  with  cytoskeletal  rearrange- 
ments and the localization of cortactin and F-actin corre- 
late with the Src-dependent phosphorylation of cortactin 
(38, 45). 
The  inability  of  senescent  HUVEC  to  migrate  corre- 
lated with an altered organization of FAS. An inverse cor- 
relation between migration and FAS organization has also 
been  described  for  fibroblasts  (8).  Furthermore,  alter- 
ations in the expression of intracellular cytoskeletal  pro- 
teins such as vinculin, which is involved with linking actin 
filaments to the extracellular matrix through integrins, are 
known  to  change  migratory  potential  (11).  Our  results 
demonstrated the phosphotyrosine- and vinculin-positive 
FAS were localized at the periphery of early passage HU- 
VEC. It is generally accepted that the peripheral associa- 
tion of FAS plays a role in cell migration (19). A migratory 
cell requires the ability to extend and stabilize lamellipo- 
dium  where  FAS  are  present  at  the  cell  front  and  rear 
(19). In the senescent HUVEC, prominent FAS were ran- 
domly scattered throughout the cytosol, which may act to 
prevent cell polarization and anchor the cells  to impede 
their migration. In addition, because the intracellular level 
of IL-let has been shown to be elevated in certain strains 
of senescent HUVEC  (15), and exogenous IL-let inhibits 
FGF-l-induced  migration of early passage  HUVEC  but 
does  not attenuate  the FGF-1  induction of Src  tyrosine 
phosphorylation  (data  not  shown),  we  suggest  that  the 
consequences of elevated intracellular IL-let in senescent 
HUVEC may not be related to the activation of FGFR-1 
substrates as they pertain to proliferation, but they may be 
related to the diminished migratory potential of senescent 
cells.  Interestingly,  the  cytosol  of  senescent  cell  FAS 
seems  to be  the major  area  of accumulation of tyrosine 
phosphorylated  proteins.  Although  the  precise  role  of 
phosphorylated tyrosine residues  in cytoskeletal  proteins 
is not fully understood, increases in phosphotyrosine levels 
have been correlated with changes in the subcellular local- 
ization of Src  and  its  substrates,  and this  may  alter  the 
structure  and  biochemical  properties  of  focal  adhesion 
sites, thereby affecting cell adhesion (38). However, it has 
also  been  shown  that  despite  the  importance  of  Y527 
phosphorylation in regulating the localization of Src to focal 
adhesion sites in established cell lines, the amino terminus 
alone may be sufficient to position Src in focal adhesions 
(21) and Src can effect cellular adhesion in a kinase-indepen- 
dent manner (3). Thus, the inability of the FGFR-1 to signal 
Src tyrosine kinase activity in senescent HUVEC may be 
related to their nonproliferative and/or nonmigratory phe- 
notype.  While it is not known whether similar  pathways 
are involved in HUVEC proliferation and migration, stud- 
ies on growth factor signaling in human diploid fibroblasts 
through  the  epidermal  growth  factor  receptor  pathway 
have demonstrated distinct mitogenic and migratory path- 
ways (19). Alternatively, since presenescent HUVEC pop- 
ulations may use exogenous FGF-1 both as a mitogen and 
as a survival factor, it is also possible that the withdrawal 
of FGF-1 from the HUVEC population may initiate an ap- 
optotic program which may be different from the human 
fibroblast population. 
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